Platelet-rich plasma injection reduces facial wrinkles

August 8, 2016

(HealthDay)—Platelet-rich plasma (PRP) intradermal injection can reduce wrinkles, especially wrinkles of the nasolabial folds (NLFs), according to a study published online July 29 in the Journal of Cosmetic Dermatology.

Naema Y. Elnehrawy, M.D., from Tanta University in Egypt, and colleagues examined the efficacy and safety of PRP intradermal for treatment of . Twenty subjects with facial wrinkles received single PRP intradermal injection and were assessed before and after eight weeks of treatment.

The researchers observed a reduction in the mean value of the Wrinkle Severity Rating Scale from 2.90 ± 0.91 before treatment to 2.10 ± 0.79 after eight weeks of treatment. Younger subjects with mild and moderate wrinkles of the NLFs had the most significant results. There was a more than 25 percent improvement in appearance for 14 of 17 subjects with NLFs. Minimal to mild side effects of PRP treatment occurred, with excellent tolerability.

"Single PRP intradermal injection is well tolerated and capable of rejuvenating the face and producing a significant correction of especially the NLFs," the authors write.

Explore further: Faster results with combined therapy for striae distensae

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Faster results with combined therapy for striae distensae

July 12, 2015

(HealthDay)—Combination therapy with platelet-rich plasma (PRP) and microdermabrasion is an effective treatment for striae distensae, according to research published online July 6 in the Journal of Cosmetic Dermatology.

Platelet-rich plasma efficacious for atrophic acne scars

January 13, 2016

(HealthDay)—Platelet-rich plasma (PRP) combined with microneedling is efficacious for the treatment of atrophic acne scars, according to a study published online Jan. 8 in the Journal of Cosmetic Dermatology.

Polycaprolactone efficient for nasolabial fold treatment

January 15, 2015

(HealthDay)—For patients with nasolabial folds (NLFs), treatment with a novel biostimulatory polycaprolactone (PCL)-based dermal filler is associated with improved long-lasting efficacy compared with nonanimal stabilized ...

Recommended for you

Intestinal fungi worsen alcoholic liver disease

May 22, 2017

Liver cirrhosis is the 12th leading cause of mortality worldwide and approximately half of those deaths are due to alcohol abuse. Yet apart from alcohol abstinence, there are no specific treatments to reduce the severity ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.